Federal Agency · National Institutes of Health
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Posted December 4, 2024
Funding
Up to $1.5M
Closes
November 5, 2027
NAICS
541714
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms.
Eligibility
Funded by NIH and Programs related to manufacturing.
Award details
Award range: Up to $1.5M. Applications close on November 5, 2027 (556 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Apr 28, 2026